Clearbridge Investments LLC cut its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 23.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 663,339 shares of the financial services provider’s stock after selling 199,866 shares during the quarter. Clearbridge Investments LLC owned about 1.58% of Trupanion worth $18,315,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of TRUP. ProShare Advisors LLC raised its position in shares of Trupanion by 33.8% during the first quarter. ProShare Advisors LLC now owns 121,417 shares of the financial services provider’s stock valued at $3,352,000 after buying an additional 30,645 shares during the last quarter. Susquehanna Fundamental Investments LLC bought a new position in Trupanion during the first quarter valued at about $473,000. 8 Knots Management LLC acquired a new position in Trupanion in the 4th quarter valued at approximately $21,165,000. Nordea Investment Management AB lifted its position in shares of Trupanion by 247.4% in the 4th quarter. Nordea Investment Management AB now owns 37,268 shares of the financial services provider’s stock worth $1,126,000 after acquiring an additional 26,540 shares during the period. Finally, Seven Eight Capital LP acquired a new stake in shares of Trupanion during the 4th quarter worth approximately $1,399,000.
Trupanion Price Performance
Shares of NASDAQ:TRUP traded down $1.39 during trading on Wednesday, reaching $32.53. The stock had a trading volume of 591,354 shares, compared to its average volume of 697,634. The stock has a market capitalization of $1.37 billion, a PE ratio of -49.72 and a beta of 1.77. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.62 and a quick ratio of 1.62. Trupanion, Inc. has a 52 week low of $19.14 and a 52 week high of $36.66. The business’s 50-day moving average price is $29.43 and its 200 day moving average price is $27.58.
Insider Buying and Selling
In other Trupanion news, SVP Emily Dreyer sold 3,125 shares of the firm’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $25.34, for a total value of $79,187.50. Following the completion of the sale, the senior vice president now owns 19,830 shares in the company, valued at approximately $502,492.20. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, CEO Darryl Rawlings bought 20,700 shares of the company’s stock in a transaction dated Tuesday, May 7th. The stock was bought at an average price of $24.14 per share, for a total transaction of $499,698.00. Following the completion of the transaction, the chief executive officer now directly owns 614,842 shares in the company, valued at approximately $14,842,285.88. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Emily Dreyer sold 3,125 shares of the company’s stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $25.34, for a total value of $79,187.50. Following the transaction, the senior vice president now directly owns 19,830 shares in the company, valued at approximately $502,492.20. The disclosure for this sale can be found here. Insiders have sold a total of 5,325 shares of company stock worth $144,586 in the last 90 days. Corporate insiders own 5.50% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. William Blair initiated coverage on shares of Trupanion in a report on Friday, July 19th. They set an “outperform” rating for the company. Bank of America raised Trupanion from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $35.00 to $49.00 in a report on Thursday, May 16th. Canaccord Genuity Group dropped their target price on Trupanion from $40.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 3rd. Finally, Piper Sandler upped their price target on Trupanion from $22.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, June 28th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Trupanion presently has an average rating of “Moderate Buy” and an average target price of $34.40.
Read Our Latest Stock Analysis on TRUP
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- What Are Trending Stocks? Trending Stocks Explained
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- How to buy stock: A step-by-step guide for beginners
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- Stock Analyst Ratings and Canadian Analyst Ratings
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.